Skip to main content
. 2023 Mar 26;15(1):2192155. doi: 10.1080/19490976.2023.2192155

Figure 2.

Figure 2.

GUDCA supplementation had therapeutic effects in improving glucose tolerance. a Fasting blood glucose. b, c OGTT, ITT and AUC. Vehicle or GUDCA-treated (100 mg/kg/d) mice on db/db mice for 8 weeks. n=10 mice in m/m group, n=9 mice in db/db+veh and db/db+gudca groups. All P values were analyzed by two-tailed Student’s t-test, **p< 0.01 versus m/m; #p< 0.05, ##p< 0.01 versus db/db+veh. All data are presented as the mean ± sd. d HOMA-IR. E TC and TG in the serum. f Serum active GLP1 levels. n=8 mice/group. All P values were analyzed by two-tailed Student’s t-test, *p< 0.05, **p< 0.01. All data are presented as the mean ± sd.